COVID: vaccine for Kids in USA

Covid, in the US, definitive green light for a Pfizer vaccine for children between 5 and 11 years old

The OK from the CDC, which came after FDA approval, launches the new phase of the American vaccination campaign. Approximately 28 million children affected. “We are at a turning point in our battle with Covid,” said President Joe Biden. He specified that the injections could begin in the week of November 8.

In the United States, the authorities have finally approved Pfizer’s coronavirus vaccine for children between the ages of 5 and 11. The green light was given by the CDCs (Centers for disease control and prevention), which recommended injections also for this age group and, in fact, launched the new phase of the vaccination campaign. In recent days there was the approval of the FDA (Food and Drug Administration), which had said yes for children at a reduced dose (one third of that for adults) and two injections three weeks apart. The decision affects approximately 28 million American children
Biden: “We are at a turning point”

“With the authorization of the vaccine for children between the ages of 5 and 11, we are at a turning point in our battle with Covid,” said US President Joe Biden. The green light of the CDC to vaccinations for children, he added, is a “big step forward in our battle to defeat the virus”. The head of the White House has specified that the vaccination campaign for children can begin in the week of 8 November.

Fda approves Pfizer aged 16 and over, now the vaccine is no longer “emergency”

The Pfizer-BioNTech vaccine has been definitively approved by the American Food and Drug Administration (FDA) for all people aged 16 and over. The vaccine, marketed as “Cominarty”, was 91% effective in preventing Covid infection. “From a legal point of view Pfizer’s becomes an approved vaccine and this opens the door to legal provisions that can lead to the obligation of vaccination” The two American pharmaceutical companies presented to the FDA the data relating to the clinical trial of 44,000 participants in the USA, the European Union, Turkey, South Africa and South America. The vaccine can now be marketed under the Comirnaty brand. Until now, the drug had been used thanks to an emergency authorization from the FDA, on 11 December 2020. Pfizer’s vaccine is a drug that can be regularly marketed and no longer limited to emergency situations. The vaccine manufactured by Pfizer-BioNTech has been definitively approved by the FDA for people aged 16 and over.

Myocarditis caused by Pfizer (in young people up to 30 years old)

Is there a connection between the cases of myocarditis diagnosed in 275 young males under the age of 30 and the administration of the Pfizer-BioNTech vaccine? Haaretz wrote that Israel’s ministry of health reported that it had found a significant number of myocarditis in young men who had received the serum. And that these are probably related to immunization.
What is this myocarditis thing after the Pfizer vaccine

A thesis disproved by Pfizer who, cited by Haaretz, stressed that he did not observe a higher rate of the disease than is normally found in the general population. The cases in Israel – said the ministry – were 275 between December last year and May 2021 out of over 5 million vaccinated. Most of the patients – according to the study carried out by the ministry – were not more than 4 days in hospital and 95% of these cases were defined as mild. The ministry’s study therefore found that “there is a probable link between those who received the second dose of Pfizer and myocarditis in young men between the ages of 16 and 30”. Pfizer – quoted by the newspaper – responded that it was aware of the Israeli study, adding that a causal link between the vaccine and inflammation has not been established.

Myocarditis is inflammation of the muscle tissue of the heart (myocardium) which unlike most heart disease tends to affect young people more often. Sometimes it can go unnoticed, it frequently heals without treatment while on some occasions it can present itself in a serious form. Its symptoms are variable. In the mildest form they can be the result of a viral infection and can be associated with fever and fatigue. In the most severe forms, heart failure develops characterized by shortness of breath, low blood pressure and loss of appetite. Sometimes it can progress to intensive care admission. Arrhythmias – which can be an early symptom of myocarditis – are also among the symptoms of the disease. But most often the disease manifests itself as a heart attack-like chest pain, since there are changes in the electrocardiogram, and some proteins normally contained in myocardial cells appear in the blood.